SV Health Investors, LLC - Q4 2020 holdings

$215 Million is the total value of SV Health Investors, LLC's 9 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 10.0% .

 Value Shares↓ Weighting
AMWL SellAMERICAN WELL CORP$42,115,000
-27.1%
1,662,646
-14.7%
20.29%
-30.7%
STRO  SUTRO BIOPHARMA INC$39,611,000
+116.0%
1,824,5420.0%19.08%
+105.4%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$34,379,000
-5.8%
1,915,2740.0%16.56%
-10.4%
DCPH  DECIPHERA PHARMACEUTICALS INC$25,679,000
+11.2%
449,9510.0%12.37%
+5.8%
KALV  KALVISTA PHARMACEUTICALS INC$25,679,000
+18.6%
1,719,5760.0%12.37%
+12.8%
MSON SellMISONIX, INC.$21,175,000
+6.4%
1,694,017
-0.1%
10.20%
+1.2%
AVRO SellAVROBIO INC$16,612,000
+3.2%
1,191,676
-3.6%
8.00%
-1.9%
XFOR  X4 PHARMACEUTICALS INC$2,003,000
-5.0%
311,4900.0%0.96%
-9.7%
TRXC  TRANSENTERIX INC$319,000
+80.2%
510,1420.0%0.15%
+71.1%
ExitCATABASIS PHARMACEUTICALS IN$0-285,765
-100.0%
-0.90%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • SVLSF VI, LLC #1
  • SV Life Sciences Fund VI (GP), L.P. #2
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSENTERIX, INC.27Q4 202024.0%
OCULAR THERAPEUTIX, INC.24Q2 202035.9%
KALVISTA PHARMACEUTICALS INC17Q4 202031.0%
DECIPHERA PHARMACEUTICALS INC17Q3 202131.0%
CATABASIS PHARMACEUTICALS, INC.15Q4 201818.2%
X4 PHARMACEUTICALS INC15Q3 20223.2%
BICYCLE THERAPEUTICS PLC14Q3 202265.4%
SUTRO BIOPHARMA INC14Q4 202119.1%
ENTELLUS MED INC12Q4 201764.4%
AVROBIO INC12Q1 202141.6%

View SV Health Investors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-07
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-12
13F-HR2020-08-14

View SV Health Investors, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (214547000.0 != 207572000.0)

Export SV Health Investors, LLC's holdings